Showcasing more than 900 suppliers from 120 countries offering a wide variety of seafood products, services, and equipment, International Boston Seafood Show/Seafood Processing America is North America’s largest must attend seafood event.
Here you will find the newest products, solutions and industry connections that will keep your business growing. This, along with an extensive education program will leave you more knowledgeable, connected and prepared to meet your customer needs.
To view Multimedia News Release, go to http://www.multivu.com/players/English/52246-international-boston-seafood-show-2012
Doctors at Children’s Hospital Boston are just another step closer to securing a cure for sickle cell disease thanks to a little help from some superstar friends. More than $1 million was raised in support of their research efforts on Sunday, January 15 during the “Play Without Pain: Children’s Sickle Cell Benefit,” a partnership with international megastar Celine Dion, Caesars Entertainment, AEG Live and Children’s Hospital Boston. Held at Caesars Palace, the evening included a performance of Celine Dion’s glamorous show directed by Grammy Awards producer Ken Ehrlich, including a touching tribute to sickle cell victims during her rendition of Billy Joel’s “Lullabye.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/54153-celine-dion-play-without-pain-children-s-sickle-cell-benefit
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
Boston Scientific Corporation (NYSE: BSX) introduces its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases, specifically atrial and ventricular arrhythmias, coronary artery disease, heart failure, heart rhythm disorders and peripheral vascular disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43509-boston-scientific-cardioteach-ipad-app
One of 46 surviving bells made by Paul Revere’s foundry before his death found a new home at Boston’s Old South Meeting House, the famed place where the Boston Tea Party began. The 876-pound Paul Revere bell, made in 1801, was acquired from the First Baptist Church of Westborough, Massachusetts. The bell was connected to the original 1766 tower clock and will once again ring out the hour as it did in Colonial Boston.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52292-historic-paul-revere-bell-now-at-boston-s-old-south-meeting-house
Blu Homes (www.bluhomes.com), a leading designer and manufacturer of beautiful, green, precision-built homes, based in Boston and San Francisco, announced today the unfolding of two eco-friendly faculty homes at Portsmouth Abbey School, one of the nation’s leading Catholic boarding schools. The two-story Blu “Evolution” homes are Energy Star-rated and LEED certifiable, and will be located on the School’s 500-acre campus on the picturesque shores of Narragansett Bay in Portsmouth, Rhode Island. The spacious and highly energy-efficient Blu Evolutions are two of a growing number of Blu homes embraced by Rhode Islanders. A Blu Element was erected in Charlestown last year while a Blu Breezehouse and another Element are currently being prepared for homeowners in Little Compton.
To view Multimedia News Release, go to http://www.multivu.com/mnr/40401-blu-homes-unfolds-green-faculty-homes-rhode-island-portsmouth-abbey-school
Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
CVS Caremark and Children’s Hospital Boston will celebrate a mutually significant milestone at Fenway Park this evening. Just prior to the Boston Red Sox/Baltimore Orioles game, the two will recognize hitting the $1 million mark in funds donated to the Hospital by CVS Caremark for children with disabilities. The relationship that brought them to this point spans more than five years and focuses on a shared commitment to helping children with disabilities. Monies donated derive from the CVS Caremark Charitable Trust and the CVS Caremark All Kids Can Program and support the Hospital’s Cerebral Palsy Program and its Center for Communication Enhancement.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52103-cvs-caremark-reaches-1-million-in-donations-children-s-hospital-boston
